Yonsei University

Catholic Kwandong University Industry Foundation

Yang Soo Jang

Young Dae Kim

Gyoon Hee Han

Sung Yu Hong

Ji Hyung Chung

Ji Hoe Heo

Il Kwon

Myeong Ki Hong

Byeong Keuk Kim

Ki Chul Hwang

Dong Ik Kim

The present invention relates to a saxatilin derivative having an increased half life and a use thereof. The saxatilin derivative of the present invention has thrombolytic ability similar to that of saxatilin, which is the mother protein, a remarkably increased protein half life, and efficiently dissolves, for long period of time, blood clots already formed in blood vessels of an animal model with a FeCl-induced carotid by using the same. Therefore, a composition containing, as an active ingredient, the saxatilin derivative of the present invention does not cause reocclusion after penetration and effectively opens to microvessels, and is thus very useful for treating angiostenosis or occlusive diseases (for example, cerebrovascular diseases, cardiovascular diseases, arteriosclerotic vascular diseases, coronary artery diseases, and peripheral vascular diseases).

Method for treating vascular stenosis or occlusive disease due to thrombi by administering a saxatilin-fc fusion protein

The present invention relates to a balloon catheter. The invention comprises: a first shaft; an expandable balloon which is attached to the front end of the first shaft; an expandable lumen which is formed inside the first shaft and to which a liquid required for expanding the balloon is provided; a second shaft which extends from the front end of the first shaft to which the balloon is attached and has a wire hole through which a guide wire passes; and a guide wire lumen, which is formed inside the second shaft and through which the guide wire passes. According to the invention, the first and second shafts are coaxially connected and the expandable lumen and the guide wire lumen are respectively formed in each shaft in order to reduce the overall diameter of the shaft, thereby facilitating surgery and improving pushability.

Balloon catheter

A bio-pin is provided. The bio-pin can be used for cell transfer and treatment, cell tracing, and targeting of specific tissues and cells using a peptide-based complex in which a cell-penetrating peptide or a cell-adhesive peptide is bound to one or both ends of a cell membrane protein, and used in a molecular imaging system, a medical appliance, and the like.

Bio-pin

Use of a compound of Formula 1 for inducing differentiation of mesenchymal stem cells to chondrocytes, and a pharmaceutical composition for treating a cartilage disease, which includes chondrocytes in which differentiation from mesenchymal stem cells is induced by the compound of Formula 1, are provided. Differentiation of the mesenchymal stem cells treated with the compound of Formula 1 to chondrocytes is specifically induced, and thus the compound can be used to effectively treat a cartilage disease such as arthritis, cartilage damage, and a cartilage defect.

Use of compounds for inducing differentiation of mesenchymal stem cells to chondrocytes

Growing community of inventors

Seoul, South Korea

Yang Soo Jang